Piscataqua Savings Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
AIM
FWIA
DLA
Piscataqua Savings Bank's BMY Position: Q2 2026 in Review
Piscataqua Savings Bank reduced its Bristol-Myers Squibb (BMY) stake by 26% in Q2 2026, selling an estimated $45.9K and leaving 2,294 shares worth $132K. The position accounts for 0.09% of the portfolio, ranked #128.
Piscataqua Savings Bank first reported a position in BMY in Q1 2021 and has held it in 22 quarters since. The position peaked at $556K in Q1 2022. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Piscataqua Savings Bank held 2,294 shares of Bristol-Myers Squibb worth $132K as of Q2 2026.
- Piscataqua Savings Bank sold 800 Bristol-Myers Squibb shares in Q2 2026, an estimated $45.9K.
- Bristol-Myers Squibb made up 0.09% of Piscataqua Savings Bank's portfolio in Q2 2026, its #128 holding.
- Piscataqua Savings Bank first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 22 quarters since.
- Piscataqua Savings Bank's Bristol-Myers Squibb position peaked at $556K in Q1 2022.
- 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Piscataqua Savings Bank's 13F filing for Q2 2026, filed 9 Jul 2026.